Private Vista LLC Has $277,000 Stake in UnitedHealth Group Inc (NYSE:UNH)

Private Vista LLC decreased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 14.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,137 shares of the healthcare conglomerate’s stock after selling 190 shares during the quarter. Private Vista LLC’s holdings in UnitedHealth Group were worth $277,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Canton Hathaway LLC acquired a new stake in UnitedHealth Group in the 1st quarter worth about $36,000. Truvestments Capital LLC acquired a new stake in UnitedHealth Group in the 1st quarter worth about $42,000. Creative Financial Designs Inc. ADV raised its stake in UnitedHealth Group by 89.6% in the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares in the last quarter. Financial Gravity Wealth Inc. acquired a new stake in UnitedHealth Group in the 1st quarter worth about $58,000. Finally, Horan Capital Advisors LLC. acquired a new stake in UnitedHealth Group in the 1st quarter worth about $68,000. Institutional investors and hedge funds own 85.87% of the company’s stock.

UNH has been the subject of several analyst reports. Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research report on Friday, July 12th. Barclays dropped their target price on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research report on Wednesday, April 17th. Oppenheimer set a $312.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price for the company in a research report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $295.06.

Shares of UnitedHealth Group stock traded down $1.02 during midday trading on Thursday, hitting $247.99. 1,942,887 shares of the company traded hands, compared to its average volume of 3,649,113. The stock has a market capitalization of $241.22 billion, a PE ratio of 19.25, a price-to-earnings-growth ratio of 1.35 and a beta of 0.61. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.73 and a current ratio of 0.67. The business has a fifty day simple moving average of $251.35. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm posted $3.14 EPS. As a group, equities research analysts predict that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.

In related news, CEO David S. Wichmann purchased 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 3rd. The shares were bought at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the acquisition, the chief executive officer now owns 904,367 shares of the company’s stock, valued at approximately $209,623,226.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the sale, the director now directly owns 187,663 shares in the company, valued at $45,412,569.37. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock worth $9,158,720 over the last ninety days. 0.87% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Why do companies pay special dividends?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.